OCERA THERAPEUTICS, INC.

Profile

Company Names

OCERA THERAPEUTICS, INC.
TRANZYME INC

Addresses

525 UNIVERSITY AVENUE, SUITE 610, PALO ALTO, CA 94301

12651 HIGH BLUFF DRIVE, SUITE 230, SAN DIEGO, CA 92130

4819 EMPEROR BOULEVARD, SUITE 400, DURHAM, NC 27703

Phone Numbers

650-475-0150
858-436-3900
919 313-4760

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$30,000,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2013-11-08 
$28,000,000.00 
$28,000,000.00 
$0.00 
Equity 
2
2013-07-15 
$0.00 
INDEFINITE 
INDEFINITE 
 
1
2010-06-21 
$2,000,000.00 
$3,000,000.00 
$1,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEAN-PAUL 
 
CASTAIGNE 
DIRECTOR
ASMACURE, INC.   |  TRANZYME INC   |  OCERA THERAPEUTICS, INC.
DONALD 
F. 
CORCORAN 
DIRECTOR
TRANZYME INC
AARON 
 
DAVIDSON 
DIRECTOR
HYPERBRANCH MEDICAL TECHNOLOGY INC   |  GEMIN X PHARMACEUTICALS INC   |  QUINNOVA PHARMACEUTICALS, INC.   |  NEURAXON(USA), INC.   |  TRANZYME INC   |  INTACT VASCULAR, INC.   |  CARDEAS PHARMA CORP   |  FORSIGHT VISION5, INC.   |  CONAVI MEDICAL CORP.   |  PERIMETER MEDICAL IMAGING AI, INC.
DAVID 
J. 
DRUTZ 
DIRECTOR
TRANZYME INC   |  METHYLGENE INC.
RICHARD 
I. 
EISENSTADT 
EXECUTIVE OFFICER
TRANZYME INC
LARS 
 
EKMAN 
DIRECTOR
ARYX THERAPEUTICS, INC.   |  AMARIN CORP PLC\UK   |  OCERA THERAPEUTICS, INC.   |  POSEIDA THERAPEUTICS, INC.   |  AEOVIAN PHARMACEUTICALS, INC.
LARS 
G 
EKMAN 
DIRECTOR
OCERA THERAPEUTICS, INC.
VIPIN 
K. 
GARG 
EXECUTIVE OFFICER, DIRECTOR
TRANZYME INC
BRENDA 
D. 
GAVIN 
DIRECTOR
TRANZYME INC   |  CELATOR PHARMACEUTICALS INC
LINDA 
S 
GRAIS 
DIRECTOR
OCERA THERAPEUTICS, INC.
LINDA 
S. 
GRAIS 
EXECUTIVE OFFICER, DIRECTOR
OCERA THERAPEUTICS, INC.   |  ARCA BIOPHARMA, INC.
JERYL 
L 
HILLEMAN 
EXECUTIVE OFFICER
OCERA THERAPEUTICS, INC.
NINA 
 
KJELLSON 
DIRECTOR
LYCERA CORP   |  PRIMERA BIOSYSTEMS INC   |  PRIMERADX, INC.   |  ALVINE PHARMACEUTICALS INC   |  SEQUEL PHARMACEUTICALS INC   |  CNS THERAPEUTICS INC   |  TRIUS THERAPEUTICS INC   |  CEBIX INCOPRATED   |  CEBIX INC   |  EIGER BIOPHARMACEUTICALS INC   |  OCERA THERAPEUTICS INC   |  WELLTOK, INC.   |  OCERA THERAPEUTICS, INC.   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  EIGER BIOPHARMACEUTICALS, INC.   |  ANNUM HEALTH, INC.   |  VINETI, INC.   |  TYRA BIOSCIENCES, INC.
DANA 
S. 
MCGOWAN 
EXECUTIVE OFFICER
OCERA THERAPEUTICS, INC.
DAVID 
S 
MOORE 
EXECUTIVE OFFICER
OCERA THERAPEUTICS, INC.
DAVID 
S. 
MOORE 
EXECUTIVE OFFICER
OCERA THERAPEUTICS, INC.   |  WHITMORE APARTMENTS REIT LLC
MICHAEL 
F 
POWELL 
DIRECTOR
OCERA THERAPEUTICS, INC.
MICHAEL 
F. 
POWELL 
DIRECTOR
ANESIVA, INC.   |  INTELLIKINE, INC.   |  LABRYS BIOLOGICS, INC.   |  OCERA THERAPEUTICS, INC.   |  SOFINNOVA VENTURE PARTNERS X, L.P.
FRANCK 
S 
ROUSSEAU 
DIRECTOR
OCERA THERAPEUTICS, INC.
FRANCK 
S. 
ROUSSEAU 
EXECUTIVE OFFICER, DIRECTOR
OCERA THERAPEUTICS, INC.
PRATIK 
 
SHAH 
DIRECTOR
CNS THERAPEUTICS INC   |  AUSPEX PHARMACEUTICALS, INC.   |  CEBIX INCOPRATED   |  ALTAIR THERAPEUTICS, INC.   |  CEBIX INC   |  SUPER GREEN BIOFUELS INC   |  OCERA THERAPEUTICS, INC.   |  ARS PHARMACEUTICALS, INC.   |  APOLLO VI EB5 FUND, LLC   |  ISABELLA INVESTMENTS MASTER FUND LTD   |  ISABELLA INVESTMENTS FEEDER FUND LP   |  ISABELLA INVESTMENTS FEEDER FUND LTD
ANNE 
M 
VANLENT 
DIRECTOR
OCERA THERAPEUTICS, INC.
ANNE 
M. 
VANLENT 
DIRECTOR, EXECUTIVE OFFICER
OCERA THERAPEUTICS, INC.   |  ONCONOVA THERAPEUTICS, INC.
ECKARD 
 
WEBER 
DIRECTOR
SEQUEL PHARMACEUTICALS INC   |  TOBIRA THERAPEUTICS, INC.   |  ASCENTA THERAPEUTICS, INC.   |  ADYNXX INC   |  TRAGARA PHARMACEUTICALS, INC.   |  OCERA THERAPEUTICS, INC.   |  SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  OREXIGEN THERAPEUTICS, INC.   |  ADYNXX, INC.   |  ADASTRA PHARMACEUTICALS, INC.
ALEX 
 
ZISSON 
DIRECTOR
ZOGENIX INC   |  QUINNOVA PHARMACEUTICALS, INC.   |  TRANZYME INC   |  CELATOR PHARMACEUTICALS INC   |  SBT HOLDINGS INC.   |  NEURANA PHARMACEUTICALS, INC.   |  CLICK THERAPEUTICS, INC.   |  CLARUS THERAPEUTICS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-11-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-11-08 
2013-07-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
 
2013-07-15 
2013-07-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2013-07-15 
2013-07-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2013-07-15 
2013-07-16
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2013-07-15 
2010-06-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
STIFEL, NICOLAUS + COMPANY INCORPORATED
793
NONE
NONE
COWEN + COMPANY LLC
7616